35158 Adaptations in the PURE registry in response to the COVID 19 pandemic: The impact of well-designed modifications in real-world data collection in a psoriasis registry

por Lynde, Charles, Papp, Kim, Beecker, Jennifer, Albrecht, Lorne, Delorme, Isabelle, Dei-Cas, Ignacio, Vieira, Antonio, Rihakova, Lenka, Gooderham, Melinda
Publicado 2022

Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry

por Gooderham, Melinda, Papp, Kim A., Lynde, Charles, Delorme, Isabelle, Beecker, Jennifer, Albrecht, Lorne, Dei-Cas, Ignacio, Brassard, Danielle, Prajapati, Vimal H., Vieira, Antonio, Rihakova, Lenka
Publicado 2022

Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America

por Papp, Kim A., Gooderham, Melinda, Beecker, Jennifer, Lynde, Charles W., Delorme, Isabelle, Dei-Cas, Ignacio, Albrecht, Lorne, Rampakakis, Emmanouil, Sampalis, John S., Vieira, Antonio, Hussein, Shamiza, Chambenoit, Olivier, Rihakova, Lenka
Publicado 2019

Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data

por Papp, Kim A., Gooderham, Melinda, Dei-Cas, Ignacio, LopezTello, Adriana, Garcia-Rodriguez, Juan C., Taveras, Carmen Yris, Rousselin, Azucena Hernández, Lavieri, Alberto, Maiolino, Mónica, Quintero, Delfina Guadalupe Villanueva, Rihakova, Lenka, Salibe, Mariano, Pertuz, Wilfran
Publicado 2022